查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1493352

美国生物感测器市场规模、份额、趋势分析报告：按技术、按应用、按最终用途、细分市场预测，2024-2030 年

U.S. Biosensors Market Size, Share & Trends Analysis Report By Technology (Electrochemical, Thermal, Piezoelectric), By Application (Medical, Food Toxicity, Bioreactor), By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10个工作天内

价格

美国生物感测器市场成长与趋势：

根据Grand View Research, Inc.的最新报告，预计到2030年美国生物感测器市场规模将达到156.1亿美元，预计2024年至2030年复合年增长率为7.13%。

该市场包括用于医疗保健、食品安全、环境监测、农业、生物技术和安全等多个行业的各种生物感测器设备、组件、技术和服务。

由于多种因素的综合作用，美国市场正在经历显着成长。关键驱动因素之一是对就地检验(POCT) 解决方案的需求不断增长，这些解决方案可在传统实验室之外提供快速、方便的诊断功能。

生物感测器在这些疾病状态的诊断、监测和管理中发挥关键作用，推动了对创新生物感测器解决方案的需求。对生物感测器技术的监管支持和核准以及对个人化医疗的日益重视也有助于市场扩张。例如，FDA核准的FoundationOne CDx 测试是一种伴同性诊断，它使用次世代定序来检测可能受益于标靶治疗的晚期癌症患者。该测试使用生物感测器来检查肿瘤 DNA，并提供可解决的基因组变化的详细资讯。

美国生物感测器市场报告亮点

  • 从技术来看，电化学领域以2023年最大的收益占有率（72.86%）引领市场。由于它们在各个领域和行业的广泛用途，这些生物感测器可以小型化并整合到便携式设备中，例如个人血糖仪，可以快速测量血糖值以进行个人血糖值管理。
  • 从应用来看，由于快速且准确的诊断工具、对个人化医疗的重视、医疗保健技术的进步等，医疗产业在 2023 年以 65.57% 的最大收益占有率引领市场。例如，2021年11月，专注于数位生物标记解决方案的美国公司Quanterix宣布发表Simoa超灵敏生物感测器平台。该平台能够检测与各种疾病相关的低丰度生物标记。
  • 按最终用途划分，由于诊所、药房和急诊等各种环境的需求，PoC（即时护理）测试领域在 2023 年以 47.67% 的最大收益占有率引领市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章美国生物感测器市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场推动要素分析
    • 市场限制因素分析
  • 美国生物感测器市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第四章美国生物感测器市场：技术预估与趋势分析

  • 2023年及2030年技术市场占有率
  • 细分仪表板
  • 美国生物感测器市场技术展望
  • 2018-2030年市场规模、预测及趋势分析
  • 热感的
  • 电化学
  • 压电
  • 其他的

第五章美国生物感测器市场：应用预估及趋势分析

  • 2023年及2030年产品市场占有率
  • 细分仪表板
  • 美国生物感测器市场前景（按应用）
  • 2018-2030年市场规模、预测及趋势分析
  • 医疗保健
  • 食品毒性
  • 反应器
  • 农业
  • 环境
  • 其他的

第六章美国生物感测器市场：最终用途估计与趋势分析

  • 2023 年及 2030 年最终用途市场占有率
  • 细分仪表板
  • 按最终用途分類的美国生物感测器市场前景
  • 2018-2030年市场规模、预测及趋势分析
  • 家庭保健诊断
  • 概念验证测试
  • 食品工业
  • 研究实验室
  • 安全和生物防御

第七章美国生物感测器市场：区域估计和趋势分析

  • 2023 年和 2030 年按地区分類的市场占有率份额
  • 美国生物感测器市场区域展望
  • 2018-2030年市场规模、预测及趋势分析
  • 西
  • 中西部
  • 东北
  • 西南
  • 东南

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商情况
  • 公司简介
    • Abbott
    • Medtronic
    • Hoffmann-La Roche Ltd
    • Dexcom, Inc.
    • SENTINEL
    • Intricon Corporation
    • Quanterix
    • Koninklijke Philips NV
    • Masimo
    • Siemens Healthcare Private Limited
    • Molecular Devices, LLC.
    • Johnson &Johnson Services, Inc.
    • Thermo Fisher Scientific Inc.
    • PerkinElmer Inc.
    • Covaris, LLC
Product Code: GVR-4-68040-281-8

U.S. Biosensors Market Growth & Trends:

The U.S. biosensors market size is anticipated to reach USD 15.61 billion by 2030 and is projected to grow at a CAGR of 7.13% from 2024 to 2030, according to a new report by Grand View Research, Inc. It encompasses various biosensor devices, components, technologies, and services used across multiple industries, such as healthcare, food safety, environmental monitoring, agriculture, biotechnology, and security.

The U.S. market is experiencing significant growth driven by a combination of factors. One key driver is the increasing demand for point-of-care testing (POCT) solutions, which offer rapid and convenient diagnostic capabilities outside of traditional laboratory settings.

Biosensors play a crucial role in diagnosing, monitoring, and managing these conditions, driving demand for innovative biosensor solutions. Regulatory support and approvals for biosensor technologies and a growing emphasis on personalized medicine are also contributing to market expansion. For instance, the FoundationOne CDx test, approved by the FDA, is a companion diagnostic utilizing next-generation sequencing to detect advanced cancer patients who could potentially benefit from targeted therapies. The test uses biosensors to examine tumor DNA to provide details on actionable genomic alterations.

U.S. Biosensors Market Report Highlights:

  • Based on technology, the electrochemical segment led the market with the largest revenue share of 72.86% in 2023, due to its diverse use across various sectors and industries, these biosensors can be miniaturized and integrated into portable devices such as personal glucose meter that provides fast measurement of blood glucose levels for personal glycemic management
  • Based on application, the medical segment led the market with the largest revenue share of 65.57%in 2023, due to the rapid and accurate diagnostic tools, emphasis on personalized medicine, advancements in healthcare technology, and others. For instance, in November 2021, Quanterix, a U.S.-based company specializing in digital biomarker solutions, announced the release of its Simoa Ultra-Sensitive Biosensors Platform. This platform empowers the detection of low-abundance biomarkers associated with various diseases
  • Based on end-use, the point of care (PoC) testing segment led the market with the largest revenue share of 47.67% in 2023, due to their demand in various settings including clinics, pharmacies, and emergency departments

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Technology
    • 1.2.2. Application
    • 1.2.3. End-use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Volume price analysis (Model 2)
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Technology outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Biosensors Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Biosensors Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
      • 3.3.2.4. Social landscape
      • 3.3.2.5. Legal landscape
      • 3.3.2.6. Environmental landscape

Chapter 4. U.S. Biosensors Market: Technology Estimates & Trend Analysis

  • 4.1. Technology Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. U.S. biosensors market By Technology Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Thermal
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Electrochemical
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.3. Piezoelectric
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.4. Optical
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. U.S. Biosensors Market: Application Estimates & Trend Analysis

  • 5.1. Product Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. U.S. biosensors market By Application Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Medical
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Food Toxicity
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.3. Bioreactor
      • 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.4. Agriculture
      • 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.5. Environment
      • 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.6. Others
      • 5.4.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. U.S. Biosensors Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. U.S. Biosensors Market By End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Home healthcare diagnostics
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. PoC testing
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Food industry
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Research Laboratories
      • 6.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Security and Bio-defense
      • 6.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. U.S. Biosensors Market: Region Estimates & Trend Analysis

  • 7.1. Regional Market Share, 2023 & 2030
  • 7.2. U.S. Biosensors Market by Region Outlook
  • 7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
    • 7.3.1. West
      • 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.2. Midwest
      • 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.3. Northeast
      • 7.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.4. Southwest
      • 7.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.3.5. Southeast
      • 7.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company heat map analysis, 2023
  • 8.4. Company Profiles
    • 8.4.1. Abbott
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Product benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Medtronic
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Product benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Hoffmann-La Roche Ltd
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Product benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Dexcom, Inc.
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Product benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. SENTINEL
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Product benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Intricon Corporation
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Product benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Quanterix
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Product benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Koninklijke Philips N.V.
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Product benchmarking
      • 8.4.8.4. Strategic initiatives
    • 8.4.9. Masimo
      • 8.4.9.1. Company overview
      • 8.4.9.2. Financial performance
      • 8.4.9.3. Product benchmarking
      • 8.4.9.4. Strategic initiatives
    • 8.4.10. Siemens Healthcare Private Limited
      • 8.4.10.1. Company overview
      • 8.4.10.2. Financial performance
      • 8.4.10.3. Product benchmarking
      • 8.4.10.4. Strategic initiatives
    • 8.4.11. Molecular Devices, LLC.
      • 8.4.11.1. Company overview
      • 8.4.11.2. Financial performance
      • 8.4.11.3. Product benchmarking
      • 8.4.11.4. Strategic initiatives
    • 8.4.12. Johnson & Johnson Services, Inc.
      • 8.4.12.1. Company overview
      • 8.4.12.2. Financial performance
      • 8.4.12.3. Product benchmarking
      • 8.4.12.4. Strategic initiatives
    • 8.4.13. Thermo Fisher Scientific Inc.
      • 8.4.13.1. Company overview
      • 8.4.13.2. Financial performance
      • 8.4.13.3. Product benchmarking
      • 8.4.13.4. Strategic initiatives
    • 8.4.14. PerkinElmer Inc.
      • 8.4.14.1. Company overview
      • 8.4.14.2. Financial performance
      • 8.4.14.3. Product benchmarking
      • 8.4.14.4. Strategic initiatives
    • 8.4.15. Covaris, LLC
      • 8.4.15.1. Company overview
      • 8.4.15.2. Financial performance
      • 8.4.15.3. Product benchmarking
      • 8.4.15.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. biosensors market, by technology, 2018 - 2030 (USD Million and Volume Unit)
  • Table 3 U.S. biosensors market, by application, 2018 - 2030 (USD Million and Volume Unit)
  • Table 4 U.S. biosensors market, by end-use, 2018 - 2030 (USD Million and Volume Unit)
  • Table 5 U.S. biosensors market, by region, 2018 - 2030 (USD Million and Volume Unit)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 U.S. biosensors market: Market outlook
  • Fig. 9 U.S. clinical trial supplies competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 U.S. biosensors market driver impact
  • Fig. 14 U.S. biosensors market restraint impact
  • Fig. 15 U.S. biosensors market: Technology movement analysis
  • Fig. 16 U.S. biosensors market: Technology outlook and key takeaways
  • Fig. 17 Thermal market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 18 Electrochemical market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 19 Piezoelectric market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 20 Optical market estimates and forecast, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 21 U.S. biosensors market: Application movement Analysis
  • Fig. 22 U.S. biosensors market: Application outlook and key takeaways
  • Fig. 23 Medical market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 24 Food toxicity market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 25 Bioreactor market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 26 Agriculture market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 27 Environment market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 28 Others market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 29 U.S. biosensors market: End-use movement analysis
  • Fig. 30 U.S. biosensors market: End-use outlook and key takeaways
  • Fig. 31 Home healthcare diagnostics market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 32 PoC Testing market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 33 Food industry market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 34 Research laboratories market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 35 Security and bio-defense market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 36 U.S. pediatric home healthcare market: Regional movement analysis
  • Fig. 37 U.S. pediatric home healthcare market: Regional outlook and key takeaways
  • Fig. 38 West market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 39 Midwest market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 40 Northeast market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 41 Southwest market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)
  • Fig. 42 Southeast market estimates and forecasts, 2018 - 2030 (USD Million and Volume Unit)